111 related articles for article (PubMed ID: 17923224)
1. Alpha-Tocopheryl succinate: toxicity and lack of anti-tumour activity in immuno-competent mice.
Ireland DJ; Kissick HT; Beilharz MW
Food Chem Toxicol; 2008 Feb; 46(2):508-12. PubMed ID: 17923224
[TBL] [Abstract][Full Text] [Related]
2. Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo.
Weber T; Lu M; Andera L; Lahm H; Gellert N; Fariss MW; Korinek V; Sattler W; Ucker DS; Terman A; Schröder A; Erl W; Brunk UT; Coffey RJ; Weber C; Neuzil J
Clin Cancer Res; 2002 Mar; 8(3):863-9. PubMed ID: 11895920
[TBL] [Abstract][Full Text] [Related]
3. Vesiculated alpha-tocopheryl succinate enhances the anti-tumor effect of dendritic cell vaccines.
Ramanathapuram LV; Hahn T; Graner MW; Katsanis E; Akporiaye ET
Cancer Immunol Immunother; 2006 Feb; 55(2):166-77. PubMed ID: 16041582
[TBL] [Abstract][Full Text] [Related]
4. Dietary administration of the proapoptotic vitamin E analogue alpha-tocopheryloxyacetic acid inhibits metastatic murine breast cancer.
Hahn T; Szabo L; Gold M; Ramanathapuram L; Hurley LH; Akporiaye ET
Cancer Res; 2006 Oct; 66(19):9374-8. PubMed ID: 17018590
[TBL] [Abstract][Full Text] [Related]
5. Tocopherol-associated protein-1 accelerates apoptosis induced by alpha-tocopheryl succinate in mesothelioma cells.
Neuzil J; Dong LF; Wang XF; Zingg JM
Biochem Biophys Res Commun; 2006 May; 343(4):1113-7. PubMed ID: 16579965
[TBL] [Abstract][Full Text] [Related]
6. alpha-Tocopheryl succinate inhibits proliferation of mesothelioma cells by selective down-regulation of fibroblast growth factor receptors.
Stapelberg M; Tomasetti M; Alleva R; Gellert N; Procopio A; Neuzil J
Biochem Biophys Res Commun; 2004 Jun; 318(3):636-41. PubMed ID: 15144885
[TBL] [Abstract][Full Text] [Related]
7. Role of thioredoxin-1 in apoptosis induction by alpha-tocopheryl succinate and TNF-related apoptosis-inducing ligand in mesothelioma cells.
Freeman RE; Neuzil J
FEBS Lett; 2006 May; 580(11):2671-6. PubMed ID: 16647070
[TBL] [Abstract][Full Text] [Related]
8. Chemo-immunotherapy of breast cancer using vesiculated alpha-tocopheryl succinate in combination with dendritic cell vaccination.
Ramanathapuram LV; Hahn T; Dial SM; Akporiaye ET
Nutr Cancer; 2005; 53(2):177-93. PubMed ID: 16573379
[TBL] [Abstract][Full Text] [Related]
9. A vitamin E analogue suppresses malignant mesothelioma in a preclinical model: a future drug against a fatal neoplastic disease?
Tomasetti M; Gellert N; Procopio A; Neuzil J
Int J Cancer; 2004 May; 109(5):641-2. PubMed ID: 14999768
[TBL] [Abstract][Full Text] [Related]
10. Alpha-tocopheryl succinate epitomizes a compound with a shift in biological activity due to pro-vitamin-to-vitamin conversion.
Neuzil J
Biochem Biophys Res Commun; 2002 May; 293(5):1309-13. PubMed ID: 12054655
[TBL] [Abstract][Full Text] [Related]
11. Vitamin E analogues and immune response in cancer treatment.
Tomasetti M; Neuzil J
Vitam Horm; 2007; 76():463-91. PubMed ID: 17628186
[TBL] [Abstract][Full Text] [Related]
12. Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications.
Greco E; Basso D; Fadi E; Padoan A; Fogar P; Zambon CF; Navaglia F; Bozzato D; Moz S; Pedrazzoli S; Plebani M
Pancreas; 2010 Jul; 39(5):662-8. PubMed ID: 20562578
[TBL] [Abstract][Full Text] [Related]
13. Induction of cancer cell apoptosis by alpha-tocopheryl succinate: molecular pathways and structural requirements.
Neuzil J; Weber T; Schröder A; Lu M; Ostermann G; Gellert N; Mayne GC; Olejnicka B; Nègre-Salvayre A; Stícha M; Coffey RJ; Weber C
FASEB J; 2001 Feb; 15(2):403-15. PubMed ID: 11156956
[TBL] [Abstract][Full Text] [Related]
14. Hepatic processing determines dual activity of alpha-tocopheryl succinate: a novel paradigm for a shift in biological activity due to pro-vitamin-to-vitamin conversion.
Neuzil J; Massa H
Biochem Biophys Res Commun; 2005 Feb; 327(4):1024-7. PubMed ID: 15652498
[TBL] [Abstract][Full Text] [Related]
15. Selective cancer cell killing by alpha-tocopheryl succinate.
Neuzil J; Weber T; Gellert N; Weber C
Br J Cancer; 2001 Jan; 84(1):87-9. PubMed ID: 11139318
[TBL] [Abstract][Full Text] [Related]
16. A peptide conjugate of vitamin E succinate targets breast cancer cells with high ErbB2 expression.
Wang XF; Birringer M; Dong LF; Veprek P; Low P; Swettenham E; Stantic M; Yuan LH; Zobalova R; Wu K; Ledvina M; Ralph SJ; Neuzil J
Cancer Res; 2007 Apr; 67(7):3337-44. PubMed ID: 17409443
[TBL] [Abstract][Full Text] [Related]
17. Alpha-tocopheryl succinate inhibits malignant mesothelioma by disrupting the fibroblast growth factor autocrine loop: mechanism and the role of oxidative stress.
Stapelberg M; Gellert N; Swettenham E; Tomasetti M; Witting PK; Procopio A; Neuzil J
J Biol Chem; 2005 Jul; 280(27):25369-76. PubMed ID: 15878867
[TBL] [Abstract][Full Text] [Related]
18. Alpha-tocopheryl succinate alters cell cycle distribution sensitising human osteosarcoma cells to methotrexate-induced apoptosis.
Alleva R; Benassi MS; Pazzaglia L; Tomasetti M; Gellert N; Borghi B; Neuzil J; Picci P
Cancer Lett; 2006 Feb; 232(2):226-35. PubMed ID: 16458119
[TBL] [Abstract][Full Text] [Related]
19. Vitamin E analogues as anticancer agents: lessons from studies with alpha-tocopheryl succinate.
Wang XF; Dong L; Zhao Y; Tomasetti M; Wu K; Neuzil J
Mol Nutr Food Res; 2006 Aug; 50(8):675-85. PubMed ID: 16835868
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer.
Ni J; Mai T; Pang ST; Haque I; Huang K; DiMaggio MA; Xie S; James NS; Kasi D; Chemler SR; Yeh S
Clin Cancer Res; 2009 Feb; 15(3):898-906. PubMed ID: 19188160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
